Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.49 | 16.65 |
| PEG Ratio (TTM) | -0.16 | 2.09 |
| P/S Ratio (TTM) | 1.56 | 1.48 |
| P/B Ratio (TTM) | 2.04 | 2.75 |
| P/FCF Ratio (TTM) | -56.62 | 10.57 |
| Price to 5YR AVG Earnings Ratio | N/A | 2.75 |
| Price to 5YR AVG FCF Ratio | N/A | 33.52 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 15.82% | 7.82% |
| ROE (TTM) | 31.10% | 18.54% |
| Net Profit Margin (TTM) | 20.88% | 10.39% |
| ROIC 5YR AVG | N/A | 6.28% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8,898.16% | 40.36% | N/A |
| Revenue | -5.02% | 8.56% | N/A |
| Net Income | 9,988.98% | 39.78% | N/A |
| Cash Flow | 616.80% | 175.67% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.79 | 1.88 |
| Quick Ratio (TTM) | 1.18 | 1.36 |
| D/E Ratio (TTM) | 0.15 | 0.97 |
| Interest Coverage (TTM) | 0.77 | 17.41 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 0.82 | 2.93 |
| LTL to 5YR AVG FCF | N/A | 8.51 |
| Shares Outstanding Growth 5YR AVG | N/A | 5.49% |